课题基金 / 基金详情

Mentoring Translational Scientists in Clinical Trial Immune Monitoring

Mentoring Translational Scientists in Clinical Trial Immune Monitoring
指导转化科学家进行临床试验免疫监测
批准号:
10670051
负责人:
Emanual M. Maverakis
金额:
$18.77万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-01 至 2026-02-28

项目摘要

项目成果

Emanual M. Maverakis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Title: Mentoring Physician Scientists in Patient-Oriented Research ABSTRACT Dr. Maverakis is a physician-scientist trained in immunogenetics, glycobiology, and big data analytics. His research focuses on the use of state-of-the-art methodologies to study patients with autoimmunity and cancer patients receiving immunotherapy. His group constructs diagnostic classifiers, as well as predictive classifiers to identify patients who will: experience a progression in disease severity, respond to a particular therapy, or develop an associated disease. With this goal in mind, Dr. Maverakis and his collaborator, Carlito Lebrilla, have created a site-specific map of the human serum glycome for use in biomarker research and discovery. Dr. Maverakis is an award-winning mentor with a strong track-record of training clinical-investigators. He is the director of the UC Davis Immune Monitoring Shared Resource and in this capacity, is charged with mentoring young clinical-scientists, especially with regards to clinical trial ancillary study design. An NIH K24 Award will be integral to his future development as a successful mentor to young clinical-investigators. It will ensure that he has protected time to teach and mentor clinical- investigators from various backgrounds to help them obtain research independence. He presents a plan for improving the quality and quantity of his mentoring, including extending his mentoring activities to other academic institutions. In addition, Dr. Maverakis proposes to augment his current patient-oriented-research by designing and conducting early stage clinical studies to explore novel treatments and their biomechanisms.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/all.14983
发表时间: 2022-03
期刊: Allergy
影响因子: 12.4
作者: [Mitamura Y, Schulz D, Oro S, Li N, Kolm I, Lang C, Ziadlou R, Tan G, Bodenmiller B, Steiger P, Marzano A, de Prost N, Caudin O, Levesque M, Stoffel C, Schmid-Grendelmeier P, Maverakis E, Akdis CA, Brüggen MC]
通讯作者: Brüggen MC
DOI: 10.1007/s13555-022-00692-3
发表时间: 2022-03
期刊: Dermatology and therapy
影响因子: 3.4
作者: [Gondo G, Hadeler E, Brownstone N, Maverakis E, Merola JF, Armstrong AW, Bhutani T, Bell SJ, Liao W]
通讯作者: Liao W
Stratedigm S100EON high-parameter flow cytometer to support multi-institutional research programs
  • 批准号:
    10431674
  • 项目类别:
  • 资助金额:
    $59.98万
  • 财政年份:
    2022
  • 负责人:
    Emanual M. Maverakis
  • 依托单位:
Mentoring Translational Scientists in Clinical Trial Immune Monitoring
  • 批准号:
    10359792
  • 项目类别:
  • 资助金额:
    $18.77万
  • 财政年份:
    2021
  • 负责人:
    Emanual M. Maverakis
  • 依托单位:
Investigation and Development of New Therapeutic Avenues for Scleroderma
  • 批准号:
    8792820
  • 项目类别:
  • 资助金额:
    $51.03万
  • 财政年份:
    2011
  • 负责人:
    Emanual M. Maverakis
  • 依托单位:
Investigation and Development of New Therapeutic Avenues for Scleroderma
  • 批准号:
    8147047
  • 项目类别:
  • 资助金额:
    $230.88万
  • 财政年份:
    2011
  • 负责人:
    Emanual M. Maverakis
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: